All lobbying filings

CGCN GROUP, LLC

Lobbying for FRESENIUS KABI USA, LLC · Healthcare company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Illinois · House · Senate · $50,000.00 income · posted Apr 20, 2026

Official filing document

Lobbying activity 4

Manufacturing

Buy America legislation, tariffs, and tax incentives.

Tariff (miscellaneous tariff bills)

Section 232 investigation into pharmaceuticals and unfair trade practices.

Taxation/Internal Revenue Code

U.S. manufacturing incentives.

Trade (domestic/foreign)

Sec. 232 investigation on pharmaceutical sector, tariffs, Buy America policies, Most Favored Nations Executive Order, reciprocal tariffs, essential medicines drug shortages related to trade agreements.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.